Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1 CNS 1

Conditions

Prostatic Neoplasms 3 Recurrence 1 Rectal Neoplasms 1 Neuroendocrine Tumors 1 Melanoma 1 Lymphoma, T-Cell, Peripheral 1 Leukemia, Myeloid, Acute 1 Leukemia, Erythroblastic, Acute 1 Hodgkin Disease 1 Breast Neoplasms 1 Brain Neoplasms 1

Interventions

Radiosurgery 114 Temozolomide 104 Bevacizumab 71 Radiotherapy 67 Magnetic Resonance Spectroscopy 67 Carboplatin 29 pembrolizumab 28 Irinotecan 26 Surgical Procedures, Operative 25 Radiation 23 Nivolumab 23 Etoposide 22 Magnetic Resonance Imaging 21 Ipilimumab 21 Erlotinib Hydrochloride 21 Cyclophosphamide 21 Surveys and Questionnaires 19 Aminolevulinic Acid 18 Specimen Handling 16 Pemetrexed 16 Mental Status and Dementia Tests 16 Cisplatin 16 Carmustine 15 Topotecan 14 Trastuzumab 13 Saline Solution 12 Neuropsychological Tests 12 Gefitinib 11 Filgrastim 11 Drug Therapy 11

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Brain Neoplasms × Salvage Therapy × Clear all

NCT03340129 2026-02-02

ABC-X

Melanoma Institute Australia

Phase 2 Recruiting

CNSDermatologic

Brain Neoplasms, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡